The U.S. government has selected the second batch of drugs up for Medicare price negotiations under the Inflation Reduction ...
On Friday, the U.S. Department of Health and Human Services (HHS) unveiled the selection of 15 additional drugs covered under ...
The Biden administration has announced the next 15 drugs chosen for Medicare negotiation, marking one of its final acts ...
The Biden administration released another list of prescriptions drugs that would be subject to price controls. The price controls for the selected drugs will become effective in 2027.
The talks around drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices ...
The US plans to slash the price it pays for the Novo Nordisk A/S blockbusters Ozempic and Wegovy, the latest drugs to be ...
In a bumper week for new biotech financings, debutante Kardigan ruled the roost with a $300 million first round that will ...
GlobalData on MSN21h
FDA beats EMA to most approved new drugs in 2024The FDA has narrowly beaten the European Medicines Agency (EMA) to the most approved drugs with a new active substance in ...
Semaglutide (Ozempic) is 1 of 15 medications that will be included in yearly price negotiations between Medicare and ...
Boehringer Ingelheim’s trio of late-stage schizophrenia failures on Thursday came a day after the Department of Health and ...
18hon MSN
The Centers for Medicare and Medicaid Services (CMS) released its second round of drug negotiation targets, a list of 15 ...
Lee Greenberger, PhD, has retired as The Leukemia & Lymphoma Society’s chief scientific officer after more than a decade in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback